Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bettina Kulle

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Bioinformatics (Oxford, England)|October 16, 2008
GSEA-SNP: applying gene set enrichment analysis to SNP data from genome-wide association studiesMarit Holden, Shiwei Deng, Leszek Wojnowski, et al.
Acta Oncologica (Stockholm, Sweden)|March 18, 2022
Characterization of long-term survivors of primary metastatic prostate cancer patients in NorwayAnne Holck Storås, Bettina Kulle Andreassen, Sophie D Fosså
European Journal of Cancer (Oxford, England : 1990)|April 11, 2018
Bladder cancer survival: Women better off in the long runBettina Kulle Andreassen, Tom Kristian Grimsrud, Erik Skaaheim Haug
BMC Genetics|February 21, 2004
Nonparametric longitudinal allele-sharing modelBettina Kulle, Karola Köhler, Albert Rosenberger, et al.
International Journal of Cancer|April 29, 2025
Let's talk about sex: Survival among females and males in a real-world cohort treated with pembrolizumab for non-small cell lung cancerKaitlyn M Tsuruda, Helga H Hektoen, Christina Aamelfot, et al.
Scandinavian Journal of Urology|May 17, 2021
The use of reTURB in T1 bladder cancer: a Norwegian population-based studyAugun Jodis Blindheim, Sophie Dorothea Fosså, Ronnie Babigumira, et al.
Acta Oncologica (Stockholm, Sweden)|September 19, 2023
Time trends in systemic treatment for patients with metastatic prostate cancer: a national cohort studyAnne Holck Storås, Kaitlyn Tsuruda, Sophie Dorothea Fosså, et al.
Prostate Cancer and Prostatic Diseases|September 8, 2021
Survival trends for patients with primary metastatic prostate cancer before and after the introduction of new antitumor drugsAnne Holck Storås, Sophie D Fosså, Giske Ursin, et al.
Diagnostic Pathology|November 23, 2021
Tumor cell invasion in blood vessels assessed by immunohistochemistry is related to decreased survival in patients with bladder cancer treated with radical cystectomyBirgitte Carlsen, Tor Audun Klingen, Bettina Kulle Andreassen, et al.
Translational Lung Cancer Research|February 17, 2025
Immortal time bias in survival outcomes when comparing treatment with chemotherapy versus immunochemotherapy for non-small cell lung cancerKaitlyn M Tsuruda, Helga H Hektoen, Denise Reis Costa, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Bioinformatics (Oxford, England)|October 16, 2008
GSEA-SNP: applying gene set enrichment analysis to SNP data from genome-wide association studiesMarit Holden, Shiwei Deng, Leszek Wojnowski, et al.
Acta Oncologica (Stockholm, Sweden)|March 18, 2022
Characterization of long-term survivors of primary metastatic prostate cancer patients in NorwayAnne Holck Storås, Bettina Kulle Andreassen, Sophie D Fosså
European Journal of Cancer (Oxford, England : 1990)|April 11, 2018
Bladder cancer survival: Women better off in the long runBettina Kulle Andreassen, Tom Kristian Grimsrud, Erik Skaaheim Haug
BMC Genetics|February 21, 2004
Nonparametric longitudinal allele-sharing modelBettina Kulle, Karola Köhler, Albert Rosenberger, et al.
International Journal of Cancer|April 29, 2025
Let's talk about sex: Survival among females and males in a real-world cohort treated with pembrolizumab for non-small cell lung cancerKaitlyn M Tsuruda, Helga H Hektoen, Christina Aamelfot, et al.
Scandinavian Journal of Urology|May 17, 2021
The use of reTURB in T1 bladder cancer: a Norwegian population-based studyAugun Jodis Blindheim, Sophie Dorothea Fosså, Ronnie Babigumira, et al.
Acta Oncologica (Stockholm, Sweden)|September 19, 2023
Time trends in systemic treatment for patients with metastatic prostate cancer: a national cohort studyAnne Holck Storås, Kaitlyn Tsuruda, Sophie Dorothea Fosså, et al.
Prostate Cancer and Prostatic Diseases|September 8, 2021
Survival trends for patients with primary metastatic prostate cancer before and after the introduction of new antitumor drugsAnne Holck Storås, Sophie D Fosså, Giske Ursin, et al.
Diagnostic Pathology|November 23, 2021
Tumor cell invasion in blood vessels assessed by immunohistochemistry is related to decreased survival in patients with bladder cancer treated with radical cystectomyBirgitte Carlsen, Tor Audun Klingen, Bettina Kulle Andreassen, et al.
Translational Lung Cancer Research|February 17, 2025
Immortal time bias in survival outcomes when comparing treatment with chemotherapy versus immunochemotherapy for non-small cell lung cancerKaitlyn M Tsuruda, Helga H Hektoen, Denise Reis Costa, et al.
Pageof 7